With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...

A group of renowned celebrities including Ishitta Arun, Lakshmi Manchu, Farah Khan, Vedang Raina, and Rashi Khanna gathered ...

Staring down the barrel of a significant birthday, I vowed in January that this would be the year I finally found something ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

Innovative treatments and devices, plus ongoing research conducted by aging experts, are providing us better insight into our ...

GLP-1 drugs like Ozempic, while effective for significant weight loss and reducing chronic disease risk, are associated with ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Eli Lilly has requested Europe's drug regulator to re-examine its opinion on the company's Alzheimer's drug, the agency said ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

Evidence points to a Mediterranean-style diet being a healthy way to eat on weight-loss medication. “This is a diet rich in ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

Furthermore, Novo Nordisk should earn important label expansions for some of its current medicines while developing new ones in other areas. Semaglutide is being tested in Alzheimer's disease. And the ...